Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
VIVEbiotech is a GMP CDMO fully focused on the Development and GMP manufacture of lentiviral vectors.
VIVEbiotech is currently working for customers based in Europe, USA and Asia, manufacturing lentiviral vectors for different applications such as for rare diseases, and for immune-cell therapies for cancer (CAR-Ts, TCRs, CAR-NKs, TILs).
One of VIVEbiotech´s main features is our specialization in virology. Based on it, our R&D Department is focusing its efforts on the development of more cost-effective processes and safer lentiviral vectors (worldwide patented technology called Lentisoma).
Language:
English
Who can attend? Everyone
Featured Presenters
Business Development Director
European PhD working on Business Development within the Biotech sector for 10 years, with more than 8 years’ experience in the CDMO sector.
Business Development Manager
Master's Degree in Molecular Biology and Biotechnology, and Master’s Degree in Project Management, combines experience in Research and Business Management.
Head of Marketing and Technology Development
PhD in Molecular Biology and Biomedicine, harmonizing Business Development and Marketing for almost a decade.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.